Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 992-C04, FOR 2674)
European Organisation for Research and Treatment of Cancer
DKTK (Project ID L637, L660)
Received: 14 April 2020
Accepted: 8 March 2021
First Online: 12 April 2021
Change Date: 28 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S13148-021-01087-5
: All patients included in our study provided their written informed consent to the bone marrow studies according to institutional standards.
: Not applicable.
: UP has received honoraria and research funding from Celgene, Janssen, Jazz, Novartis and Amgen. All the other authors declare that they have no competing interests.